However, real-world use often brings unanticipated consequences due to systemic cell growth
Then came the Q&A portion of the hour
Genetically predicted lower BMI via GLP-1R activation was associated with better well-being, including better life satisfaction, lower neuroticism, fewer depressive symptoms, and greater positive affect
Wittich CM, Burkle CM, Lanier WL
Time to Results: Noticeable Appetite Reduction: GLP-1s (semaglutide, tirzepatide): 1-2 weeks Phentermine: 1-3 days Phentermine-topiramate: 1-2 weeks Naltrexone-bupropion: 4-8 weeks Orlistat: Doesnt reduce appetite Measurable Weight Loss: Tirzepatide: 5-8% by week 20, 15-22% by week 72 Semaglutide: 5-7% by week 20, 10-15% by week 68 Phentermine-topiramate: 5-6% by week 28 Others: 3-5% by week 24-28 GLP-1s produce steady, sustained weight loss over 16-20 months
This hormone plays several important roles: it signals your brain that you're full, slows the rate at which food leaves your stomach, and helps regulate blood sugar by stimulating insulin release